Concepedia

Publication | Open Access

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer

DOIFull Paper Access

90

Citations

23

References

2019

Year

Peter Schmid, Catherine Harper‐Wynne, M. Ferreira, Sidharth Dubey, Stephen Chan, Andreas Makris, Gia Nemsadze, Adrian Murray Brunt, Sherko Küemmel, Isabel Ruíz-Camps,
JAMA Oncology

Abstract

ClinicalTrials.gov identifier: NCT02216786 and EudraCT number: 2013-002403-34.

References

YearCitations

Page 1